Diagnostic Criteria Used in i‐ PRF Trials for Articular Temporomandibular Disorders: A Scoping Review
- 10 November 2026
- journal article
- review article
- Published by Wiley in Oral Diseases
Abstract
Objective: Injectable platelet‐rich fibrin (i‐PRF) is increasingly used for articular temporomandibular disorders (TMD), but it is unclear whether randomised controlled trials (RCTs) report validated diagnostic criteria for participant enrolment. This scoping review maps the diagnostic instruments reported in i‐PRF RCTs for articular TMD. It does not assess whether diagnostic systems were applied correctly or the accuracy of diagnoses. Methods: Following the JBI framework and PRISMA‐ScR, RCTs evaluating i‐PRF for articular TMD and reporting pain and/or maximum mouth opening were searched in six databases, without date or language restrictions, plus grey literature, trial registries and reference lists. Diagnostic approaches, sample characteristics, imaging, interventions, comparators, follow‐up and adverse events were charted. Results: Thirteen RCTs were included. Three reported DC/TMD for enrolment, two from the same research group. Five reported Wilkes staging, three reported imaging without a clinical diagnostic system, and two reported no diagnostic criterion. No trial reported RDC/TMD. Conclusion: Fewer than a quarter of i‐PRF RCTs reported enrolment using a currently validated diagnostic system. This methodological finding does not indicate whether i‐PRF is effective. Future trials should use DC/TMD and report diagnostic procedures in full.Keywords
This publication has 28 references indexed in Scilit:
- Does concentrated growth factor provide better outcomes than platelet-rich fibrin or arthrocentesis in the management of temporomandibular disorders?International Journal of Oral and Maxillofacial Surgery, 2026
- Efficacy of injectable platelet-rich fibrin and concentrated platelet-rich fibrin injections combined with arthrocentesis in the management of temporomandibular joint internal disorders: Randomized clinical trialJournal of Cranio-Maxillofacial Surgery, 2026
- Platelet concentrates and arthrocentesis as therapeutic options for temporomandibular joint osteoarthritis: A systematic review of systematic reviewsAdvances in Oral and Maxillofacial Surgery, 2025
- Evaluation of intra-articular injection of injectable platelet-rich fibrin, anterior repositioning splint and arthrocentesis in treatment of temporomandibular joint internal derangementBritish Journal of Oral and Maxillofacial Surgery, 2024
- Classification and Diagnosis of Temporomandibular Disorders and Temporomandibular Disorder PainDental Clinics of North America, 2023
- A systematic review and meta-analysis of randomized controlled trials comparing arthrocentesis with conservative management for painful temporomandibular joint disorderInternational Journal of Oral and Maxillofacial Surgery, 2023
- Injectable platelet-rich fibrin as treatment for temporomandibular joint osteoarthritis: A randomized controlled clinical trialJournal of Cranio-Maxillofacial Surgery, 2022
- Treatment of temporomandibular joint disc displacement using arthrocentesis combined with injectable platelet rich fibrin versus arthrocentesis aloneJournal of Dental Sciences, 2021
- Randomised controlled trial of arthrocentesis with or without PRF for internal derangement of the TMJJournal of Cranio-Maxillofacial Surgery, 2021
- Internal Derangements of the Temporomandibular Joint: Pathological VariationsJAMA Otolaryngology–Head & Neck Surgery, 1989